Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | CNR1 | P21554 | 10/20 | 0.42 |
| ▸ | CNR2 | P34972 | 9/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4263013 | 0.87 | CNR1 (0.50) | ESR1ESR2CNR1CNR2PTGS2 | |
| SCHEMBL5916439 | 0.85 | CNR1 (0.56) | CNR1CNR2PTGS2CYP3A4 | |
| SCHEMBL2027212 | 0.84 | CNR1 (0.58) | CNR1CNR2PTGS2 | |
| SCHEMBL69123 | 0.84 | CNR1 (0.58) | CNR1CNR2PTGS2 | |
| SCHEMBL31545799 | 0.84 | CNR1 (0.58) | CNR1CNR2PTGS2 | |
| SCHEMBL3436068 | 0.81 | GABRA1 (0.50) | GABRA1GABRB2ESR1ESR2CNR1 | |
| SCHEMBL5648833 | 0.79 | CNR1 (0.43) | ESR1ESR2CNR1CNR2AR | |
| SCHEMBL1835827 | 0.78 | CNR2 (0.38) | ESR1ESR2CNR1CNR2AR | |
| SCHEMBL20243855 | 0.78 | ESR1 (0.39) | GABRA1GABRB2ESR1ESR2CNR1 | |
| SCHEMBL199692 | 0.77 | ESR1 (0.65) | ESR1ESR2CNR1CNR2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284621-A1 | CANNABINOIDS AND USES THEREOF | CORBUS PHARMACEUTICALS, INC. | 2021-09-16 | — | — | US | disclosed |
| US-20210284621-A1 | CANNABINOIDS AND USES THEREOF | CORBUS PHARMACEUTICALS, INC. | 2021-09-16 | — | — | US | disclosed |
| US-9517989-B2 | 2-cycloalkyl resorcinol cannabinergic ligands | NORTHEASTERN UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150274623-A1 | 2-CYCLOALKYL RESORCINOL CANNABINERGIC LIGANDS | Northeastern Uiversity (US) | 2015-10-01 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20060183922-A1 | CB2-selective cannabinoid derivatives | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284621-A1 | CANNABINOIDS AND USES THEREOF | CNR2, CNR1, FAAH | GABRA1 558/4885GABRB2 750/4885ESR1 1768/4885 |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | GABRA1 1441/4885GABRB2 2705/4885ESR1 1265/4885 |
| US-20060183922-A1 | CB2-selective cannabinoid derivatives | CNR2, CNR1, GPR18 | GABRA1 259/4885GABRB2 237/4885ESR1 535/4885 |
| US-20150274623-A1 | 2-CYCLOALKYL RESORCINOL CANNABINERGIC LIGANDS | CNR2, CNR1, OPRL1 | GABRA1 217/4885GABRB2 144/4885ESR1 3015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.